Alexion Pharm Inc
(ALXN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 489,200 | 603,400 | 67,600 | -510,500 | 557,600 |
| Depreciation Amortization | 75,600 | 2,382,700 | 2,307,600 | 2,232,400 | 89,300 |
| Income taxes - deferred | 52,900 | -283,400 | -174,200 | -226,600 | 49,000 |
| Accounts receivable | -87,900 | -139,400 | -183,500 | -137,600 | -120,900 |
| Other Working Capital | -254,800 | -33,800 | -262,400 | -296,000 | -224,700 |
| Other Operating Activity | 362,600 | 473,400 | 407,300 | 277,900 | 199,300 |
| Operating Cash Flow | $637,600 | $3,002,900 | $2,162,400 | $1,339,600 | $549,600 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,700 | 119,100 | 160,300 | 142,700 | 118,400 |
| PPE Investments | -20,200 | -106,700 | -29,200 | -18,400 | -12,200 |
| Net Acquisitions | N/A | -2,111,900 | -2,111,900 | -837,700 | -837,700 |
| Purchase Of Investment | N/A | N/A | -38,100 | -38,100 | -34,500 |
| Purchase Sale Intangibles | -110,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -110,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-133,900 | $-2,099,500 | $-2,018,900 | $-751,500 | $-766,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | -65,300 | N/A |
| Debt Repayment | -32,600 | -130,600 | -97,900 | N/A | -32,600 |
| Common Stock Issued | 15,200 | N/A | 22,100 | 12,900 | 2,800 |
| Common Stock Repurchased | N/A | -510,800 | -434,300 | -360,800 | -107,100 |
| Other Financing Activity | -1,300 | 29,500 | -28,000 | -17,500 | -1,300 |
| Financing Cash Flow | $-18,700 | $-611,900 | $-538,100 | $-430,700 | $-138,200 |
| Exchange Rate Effect | -13,100 | 19,500 | -500 | -8,100 | -13,200 |
| Beginning Cash Position | 3,034,600 | 2,723,600 | 2,723,600 | 2,723,600 | 2,723,600 |
| End Cash Position | 3,506,500 | 3,034,600 | 2,328,500 | 2,872,900 | 2,355,800 |
| Net Cash Flow | $471,900 | $311,000 | $-395,100 | $149,300 | $-367,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 637,600 | 3,002,900 | 2,162,400 | 1,339,600 | 549,600 |
| Capital Expenditure | -20,200 | -106,700 | -29,200 | -18,400 | -12,200 |
| Free Cash Flow | 617,400 | 2,896,200 | 2,133,200 | 1,321,200 | 537,400 |